FDA approves new treatment for adults with mantle cell lymphoma - FDA.gov

New York Daily News

FDA approves new treatment for adults with mantle cell lymphoma FDA.gov The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy. “Mantle cell lymphoma is a particularly aggressive ... AstraZeneca wins US approval for lymphoma drugABC News FDA Approves Acalabrutinib (Calquence) for Mantle Cell LymphomaMedscape Mantle Cell Lymphoma Drug Gets FDA OKPharmacy Times HealthDay -MedPage Today -UPI.com -Cancer Therapy Advisor all 30 news articles »

from Health - Google News http://ift.tt/2zWcTlc